Given the significance of tumor antigen-specific T cells in the draining lymph nodes for the response to anti-PD-1/PD-L1 therapy [58], our co-transferred ACT experiment revealed a limited presence of p16OE CD8+ T cells in the spleen and draining lymph nodes. The gene discussed is PDCD1; the disease is neoplasm.